Search Results - "Battisti, Nicolò M.L."

Immune checkpoint inhibitors and cardiovascular toxicity by Lyon, Alexander R, Yousaf, Nadia, Battisti, Nicolò M L, Moslehi, Javid, Larkin, James

“…Immune checkpoint inhibitors are a new class of anticancer therapies that amplify T-cell-mediated immune responses against cancer cells. Immune checkpoint…”
Get full text

Geriatric Oncology as an Unmet Workforce Training Need in the United Kingdom—A Narrative Review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group by Khoury, Emma G., Nuamek, Thitikorn, Heritage, Sophie, Fulton-Ward, Taylor, Kucharczak, Joanna, Ng, Cassandra, Kalsi, Tania, Gomes, Fabio, Lind, Michael J., Battisti, Nicolò M. L., Cheung, Kwok-Leung, Parks, Ruth, Pearce, Jessica, Baxter, Mark A.

“…Cancer is a disease associated with ageing. Managing cancer in older adults may prove challenging owing to pre-existing frailty, comorbidity, and wider…”
Get full text

Using Big Data in oncology to prospectively impact clinical patient care: A proof of concept study by Dougoud-Chauvin, Vérène, Lee, Jae Jin, Santos, Edgardo, Williams, Vonetta L., Battisti, Nicolò M.L., Ghia, Kavita, Sehovic, Marina, Croft, Cortlin, Kim, Jongphil, Balducci, Lodovico, Kish, Julie A., Extermann, Martine

“…Big Data is widely seen as a major opportunity for progress in the practice of personalized medicine, attracting the attention from medical societies and…”
Get full text

Abstract PO1-17-02: Real-world outcomes of systemic therapy for advanced triple-negative breast cancer: a tertiary centre experience by Zhang, Shuai, Coriano, Matilde, Eochagain, Colm Mac, Yang, Dorothy, Yiu, Daniel, Ring, Alistair, Battisti, Nicolo M.L.

“…Abstract Background Despite recent therapeutic developments for advanced triple-negative breast cancer (aTNBC), outcomes are still suboptimal for a significant…”
Get full text

Abstract PO2-02-09: Pathological complete response to neoadjuvant systemic therapy and its predictive factors among early breast cancer subtypes: the emerging role of HER2 by Corianò, Matilde, Battisti, Nicolo M.L., Aziz, Hala, Hogan, Nalinie Joharatnam, Musolino, Antonino, Ring, Alistair

“…Abstract Purpose Pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) for breast cancer (BC) is a prognostic factor for relapse-free and…”
Get full text

Abstract P6-08-04: Geographical variation of social deprivation, cardiovascular and other comorbidities in 226,516 patients with early breast cancer in England: results from a National Registry Dataset Analysis by Waterhouse, Jasmin V, Welch, Catherine A., Battisti, Nicolo M.L., Adlam, David, Sweeting, Michael J., Paley, Lizz, Lambert, Paul, Deanfield, John E., de Belder, Mark, Peake, Michael D, Ring, Alistair

“…Abstract Background In England, as for many countries, there are geographical variations in treatment uptake and outcomes for patients with early breast cancer…”
Get full text